[go: up one dir, main page]

AU2001238700A1 - Compositions and methods of use of het, a novel modulator of estrogen action - Google Patents

Compositions and methods of use of het, a novel modulator of estrogen action

Info

Publication number
AU2001238700A1
AU2001238700A1 AU2001238700A AU3870001A AU2001238700A1 AU 2001238700 A1 AU2001238700 A1 AU 2001238700A1 AU 2001238700 A AU2001238700 A AU 2001238700A AU 3870001 A AU3870001 A AU 3870001A AU 2001238700 A1 AU2001238700 A1 AU 2001238700A1
Authority
AU
Australia
Prior art keywords
het
compositions
methods
estrogen action
novel modulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001238700A
Inventor
S. A. Fuqua
A. V. Lee
Steffi Oesterreich
C. K. Osborne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU2001238700A1 publication Critical patent/AU2001238700A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001238700A 2000-02-22 2001-02-22 Compositions and methods of use of het, a novel modulator of estrogen action Abandoned AU2001238700A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18409700P 2000-02-22 2000-02-22
US60184097 2000-02-22
PCT/US2001/006135 WO2001063292A2 (en) 2000-02-22 2001-02-22 Compositions and methods of use of het, a novel modulator of estrogen action

Publications (1)

Publication Number Publication Date
AU2001238700A1 true AU2001238700A1 (en) 2001-09-03

Family

ID=22675530

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001238700A Abandoned AU2001238700A1 (en) 2000-02-22 2001-02-22 Compositions and methods of use of het, a novel modulator of estrogen action

Country Status (2)

Country Link
AU (1) AU2001238700A1 (en)
WO (1) WO2001063292A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127217D0 (en) * 2001-11-12 2002-01-02 Univ Bristol MET a novel suppresser of estrogen induced transcription
AU2003253050A1 (en) * 2002-07-12 2004-02-02 Center For Genetic Engineering And Biotechnology (Cigb) Diagnosis and therapy of breast tumours resistant to antiestrogen treatment
MX2012014431A (en) 2010-06-10 2013-02-26 Aragon Pharmaceuticals Inc MODULAR RECEPTOR OF STROGENS AND USES OF THE SAME.
MX357496B (en) 2011-12-14 2018-07-11 Seragon Pharmaceuticals Inc Fluorinated estrogen receptor modulators and uses thereof.
EP3655531B1 (en) * 2017-07-18 2024-09-04 Exosome Diagnostics, Inc. Sequencing of nucleic acids associated with exosomal isolation from patients with glioblastoma multiforme
CN107368709A (en) * 2017-08-14 2017-11-21 江南大学 The new method that the external intensity of promoter based on AFM characterizes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028466A1 (en) * 1997-12-04 1999-06-10 Board Of Regents, The University Of Texas System Compositions and methods of use of het

Also Published As

Publication number Publication date
WO2001063292A3 (en) 2002-03-28
WO2001063292A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001291222A1 (en) Wax-modified thermosettable compositions
AU2001243502A1 (en) Registry emulation
AU2001288623A1 (en) Fxr modulators
AU2002213467A1 (en) Modulation of ccr4 function
AU2001286677A1 (en) Controlled release of substances
AU2000279411A1 (en) New pigments and compositions containing them
AU2023301A (en) Improved prosthesis
AU2001253179A1 (en) Defoamer compositions and uses therefor
AUPQ998100A0 (en) Application development
AU2001266926A1 (en) Hemostatic compositions, devices and methods
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2002223178A1 (en) Easy open end and can for powders
AU2002213466A1 (en) Compounds and methods for modulating ccr4 function
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001280721A1 (en) Compositions of iodonium compounds and methods and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001238700A1 (en) Compositions and methods of use of het, a novel modulator of estrogen action
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU2001280588A1 (en) Methods of modulating angiogenesis
AU2001259252A1 (en) Neuroprotective compositions
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001232089A1 (en) Compound, composition and use
AU2001232080A1 (en) Compound, compositions and use